Top Growth Trends in the Viral Gastroenteritis Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the viral gastroenteritis market right now?
The market size for viral gastroenteritis has seen consistent growth in the past few years. The market is forecasted to increase from $6.75 billion in 2024 to $7.08 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.0%. The reasons for this growth pattern over the historic period include the increased presence of viral infections, worldwide hygiene habits, progress in diagnostic techniques, global tourism and commuting patterns, and various climatic and environmental elements.
How fast Is the viral gastroenteritis market expected to grow, and what’s its future value?
The market size of viral gastroenteritis is set to witness robust expansion in the upcoming years. It is predicted to reach a worth of $8.73 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. This growth during the prognosis period can be credited to the worldwide health readiness, effects of climate change, the one health approach, epidemiological surveillance systems, and an increase in education and public awareness. Some of the significant trends noted for the prognosis period include the evolution of vaccines, innovative diagnostic methods, the application of telemedicine in identifying diseases, joint research programs, personalized medication strategies, and the introduction of digital healthcare solutions.
Get your viral gastroenteritis market report here!
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report
What are the leading drivers of growth in the viral gastroenteritis market?
The escalating instances of gastrointestinal ailments are anticipated to boost the viral gastroenteritis market’s development. Gastrointestinal (GI) disorders are diseases that affect any area within or on the gastrointestinal tract. The medicines and diagnostic treatments for viral gastroenteritis provide necessary and suitable medications for those afflicted. For example, in September 2023, the IBD Clinical and Research Centre announced through their Impact of IBD Report 2023 that over 320,000 individuals in Canada suffer from inflammatory bowel disease (IBD) with an incidence of 825 per 100,000 in 2023. This Canada-based association is committed to enhancing the lifestyles of patients with Crohn’s disease and ulcerative colitis. As the incidence of these diseases is projected to rise by 2.44% each year, by 2035, 1.1% of the populace, or about 470,000 Canadians, are expected to suffer from IBD. Consequently, the rise in gastrointestinal disorders is fuelling the expansion of the viral gastroenteritis market.
What are the key segments defining the viral gastroenteritis market?
The viral gastroenteritis market covered in this report is segmented –
1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp
Who are the key players steering the development of the viral gastroenteritis market?
Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited
What emerging trends are influencing the growth of the viral gastroenteritis market?
The primary trend escalating in recognition within the viral gastroenteritis market involves product innovation. The heavyweight corporations in this market are actively working towards crafting new products to solidify their standing. One such example would be the UK-based biopharmaceutical firm, GlaxoSmithKline PLC. In November 2022, this company procured approval from the US Food and Drug Administration (FDA) for their oral-dosing applicator-only variant (in liquid form) of ROTARIX, which aims to prevent rotavirus gastroenteritis in infants. This novel formulation style is advantageous for healthcare professionals as it dispenses the need for reconstituting the vaccine dosage at the point of use. The sanctioning by the FDA is reinforced by international clinical trial results, illustrating safety, tolerability as opposed to lyophilized formulation, and non-inferiority in terms of immunogenicity.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127
Which regions are most influential in expanding the viral gastroenteritis market?
North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Forklift Truck Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report
Smart And Mobile Supply Chain Solutions Global Market Report 2024
Warehouse Execution System Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
